preclinical models

Related by string. Preclinical Models * Preclinical : preclinical compounds . preclinical toxicology . preclinical studies . preclinical efficacy . vivo preclinical . preclinical pharmacology . Preclinical studies suggest / modeled . Models . modeling . Modeling . Modeled . Model : Super Late Model . Super Late Models . Next Inning model . Late Model Series . Limited Late Model . 3D modeling * *

Related by context. Frequent words. (Click for all words.) 73 preclinical studies 70 Preclinical studies 66 vitro studies 66 preclinical 65 anti angiogenic 65 vivo 64 antitumor activity 63 potent inhibitor 62 INGN 61 small molecule inhibitors 61 tolerability profile 60 HDAC inhibitors 60 oral bioavailability 60 receptor agonist 59 CYT# 59 small molecule 59 Homspera 59 neuroprotective 58 hematologic malignancies 58 Hedgehog pathway 58 TLR7 58 neuroprotection 58 humanized monoclonal antibody 57 Preclinical 57 MGCD# [001] 57 Azixa 57 small molecule inhibitor 57 immunotherapeutic 57 GM CSF 57 chemotherapeutics 57 pharmacologic 56 oncology indications 56 RNAi therapeutic 56 pharmacodynamic 56 vitro 56 kinase inhibitor 56 XL# [003] 56 elesclomol 56 solid tumors 56 disease modifying 56 ISIS # 56 RDEA# 56 antiviral activity 56 PI3K 56 kinase inhibitors 56 cytotoxicity 55 tolerability 55 monoclonal antibody 55 cytotoxic 55 selective inhibitor 55 pharmacokinetic profile 55 MultiStem 55 anticancer agents 55 immune mediated 55 MDV# 55 receptor antagonist 55 HE# [002] 55 inhibition 55 ARRY 54 IMGN# 54 agonist 54 monoclonal antibodies 54 CD# [002] 54 HspE7 54 siRNA 54 pharmacokinetic 54 investigational compound 54 human monoclonal antibody 54 Phase IIa 54 antisense drugs 54 therapeutic antibodies 54 Atiprimod 54 NGX# 54 Alpharadin 54 INCB# [002] 54 neurotoxicity 54 eculizumab 54 AP# [003] 54 HDAC 54 tesetaxel 54 bortezomib 54 Perifosine 54 Tβ4 53 Inhibition 53 signaling pathways 53 neurodegenerative diseases 53 hematological malignancies 53 inflammatory cytokines 53 immune responses 53 upregulated 53 autoimmune diseases 53 Hsp# [002] 53 inflammatory diseases 53 agonists 53 MLN# 53 diabetic nephropathy 53 Phase 2a clinical 53 cytokine 53 oral dosing 53 fusion protein 53 inflammatory mediators

Back to home page